{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:34:29Z","timestamp":1792028069173,"version":"4.4.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,6,27]]},"DOI":"10.1097\/01.tp.0000266578.45634.4f","type":"journal-article","created":{"date-parts":[[2007,6,20]],"date-time":"2007-06-20T08:03:58Z","timestamp":1182326638000},"page":"1557-1562","source":"Crossref","is-referenced-by-count":58,"title":["Safety of Treatment of Latent Tuberculosis Infection in Compensated Cirrhotic Patients During Transplant Candidacy Period"],"prefix":"10.1097","volume":"83","author":[{"given":"Alex W.","family":"Jahng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thao","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanchi","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Joyner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210129","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/00007890-199705150-00015","article-title":"Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA.","volume":"63","author":"Aguado","year":"1997","journal-title":"Transplantation"},{"key":"R2-7-20210129","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0962-8479(92)90092-X","article-title":"Liver transplantation: An unheralded probable risk for tuberculosis.","volume":"73","author":"Salizzoni","year":"1992","journal-title":"Tuber Lung Dis"},{"key":"R3-7-20210129","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/514993","article-title":"M. tuberculosis infection in solid organ transplant recipients: Impact and implications for management.","volume":"27","author":"Singh","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R4-7-20210129","first-page":"3681","article-title":"Outcome of severe pneumonias after orthotopic liver transplantation.","volume":"26","author":"Stoblen","year":"1994","journal-title":"Transplant Proc"},{"key":"R5-7-20210129","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1432-2277.1996.tb00919.x","article-title":"Tuberculosis following liver transplantation: Report of a case and review of the literature.","volume":"9","author":"Nishizaki","year":"1996","journal-title":"Transpl Int"},{"key":"R6-7-20210129","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1399-0012.1992.tb00590.x","article-title":"Mycobacterial infection after liver transplantation: A report of three cases and review of the literature.","volume":"6","author":"Sterneck","year":"1992","journal-title":"Clin Transplant"},{"issue":"RR12","key":"R7-7-20210129","first-page":"1","article-title":"Controlling tuberculosis in the United States.","volume":"54","year":"2005","journal-title":"MMWR"},{"key":"R8-7-20210129","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection.","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R9-7-20210129","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1111\/j.1600-6143.2005.01087.x","article-title":"Management of tuberculosis in the transplant recipient.","volume":"5","author":"Rubin","year":"2005","journal-title":"Am J Transplant"},{"key":"R10-7-20210129","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1086\/427692","article-title":"Mycobacterium tuberculosis infection in recipients of solid organ transplants.","volume":"40","author":"Munoz","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R11-7-20210129","first-page":"847","article-title":"How much isoniazid is needed for prevention of tuberculosis in immunocompetent patients.","volume":"3","author":"Comstock","year":"1999","journal-title":"INt J Tuberc Lung Dis"},{"key":"R12-7-20210129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1164\/ajrccm\/145.1.36","article-title":"A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong.","volume":"145","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"R13-7-20210129","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1164\/rccm.200405-584PP","article-title":"Considering the role of four months of rifampicin in the treatment of latent tuberculosis infection.","volume":"170","author":"Reichman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R14-7-20210129","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.7326\/0003-4819-71-6-1113","article-title":"Serum transaminase elevations and other hepatic abnormalities in patients receiving isoniazid.","volume":"71","author":"Scharer","year":"1969","journal-title":"Ann Intern Med"},{"key":"R15-7-20210129","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1001\/jama.1972.03200110051009","article-title":"Isoniazid toxicity. A prospective study in secondary chemoprophylaxis.","volume":"220","author":"Byrd","year":"1972","journal-title":"JAMA"},{"key":"R16-7-20210129","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1007\/BF02090381","article-title":"Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation.","volume":"39","author":"Farrell","year":"1994","journal-title":"Dig Dis Sci"},{"key":"R17-7-20210129","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00007890-199408000-00022","article-title":"Acute hepatic failure in seven patients after prophylaxis and therapy with antituberculous agents. Successful treatment with orthotopic liver transplantation.","volume":"58","author":"Meyers","year":"1994","journal-title":"Transplantation"},{"key":"R18-7-20210129","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/jama.281.11.1014","article-title":"Hepatotoxicity associated with isoniazid preventive therapy. A 7-year survey from a public health tuberculosis clinic.","volume":"281","author":"Nolan","year":"1999","journal-title":"JAMA"},{"key":"R19-7-20210129","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1164\/rccm.200303-390OC","article-title":"Use of Isoniazid for latent tuberculosis infection in a public health clinic.","volume":"168","author":"LoBue","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R20-7-20210129","first-page":"991","article-title":"Isoniazid-related hepatitis: A US Public Health Service cooperative surveillance study.","volume":"117","author":"Kopanoff","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"R21-7-20210129","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0016-5085(19)32568-5","article-title":"Liver physiology and disease: Isoniazid-associated hepatitis in 114 patients.","volume":"69","author":"Black","year":"1975","journal-title":"Gastroenterology"},{"key":"R22-7-20210129","article-title":"Core curriculum on tuberculosis. What the clinician should know, 4th ed.","year":"2000"},{"key":"R23-7-20210129","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2165\/00003088-198409060-00003","article-title":"Clinical pharmacokinetics of the antituberculosis drugs.","volume":"9","author":"Holdiness","year":"1984","journal-title":"Clin Pharmacokinet"},{"key":"R24-7-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00004836-198109000-00012","article-title":"Risk factors for isoniazid (INH)-induced liver dysfunction.","volume":"3","author":"Dickinson","year":"1981","journal-title":"J Clin Gastroenterol"},{"key":"R25-7-20210129","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1164\/ajrccm\/145.2_Pt_1.494","article-title":"Isoniazid-associated hepatitis deaths: A review of available information.","volume":"145","author":"Snider","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"R26-7-20210129","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1164\/ajrccm.157.6.9711039","article-title":"Antituberculosis drug-induced hepatotoxicity. The role of hepatitis C and the human immunodeficiecy virus.","volume":"157","author":"Ungo","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"R27-7-20210129","first-page":"203","article-title":"Hepatitis cases in isoniazid treated groups and in a control group.","volume":"51","author":"Riska","year":"1976","journal-title":"Bull Int Union Tuberc"},{"key":"R28-7-20210129","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1378\/chest.99.2.465","article-title":"Toxic hepatitis with isoniazid and RIF: A meta-analysis.","volume":"99","author":"Steele","year":"1991","journal-title":"Chest"},{"key":"R29-7-20210129","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/gut.50.3.436","article-title":"Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis.","volume":"50","author":"Prince","year":"2002","journal-title":"Gut"},{"key":"R30-7-20210129","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1086\/499244","article-title":"Severe or fatal liver injury in 50 patients in the United States taking rifampbin and pyrazinamide for latent tuberculosis infection.","volume":"42","author":"Ijaz","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R31-7-20210129","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1086\/516138","article-title":"Interactions between tacrolimus and antimicrobial agents.","volume":"25","author":"Paterson","year":"1997","journal-title":"Clin Infect Dis"},{"key":"R32-7-20210129","first-page":"73","article-title":"Drug interaction between cyclosporine and two antimicrobial agents, josamycin and rifampicin, in organ-transplanted patients.","volume":"16","author":"Capone","year":"1996","journal-title":"Int J Clin Pharmacol Res"},{"key":"R33-7-20210129","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00006454-200007000-00008","article-title":"Mycobacterium tuberculosis infection in pediatric liver transplant recipients.","volume":"19","author":"Verma","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R34-7-20210129","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/00007890-200211270-00006","article-title":"Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area.","volume":"74","author":"Benito","year":"2002","journal-title":"Transplantation"},{"key":"R35-7-20210129","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: Treatment of tuberculosis.","volume":"167","author":"Blumberg","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R36-7-20210129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00007890-200001150-00013","article-title":"Tuberculosis in orthotopic liver transplant patients: Increased toxicity of recommended agents; cure of disseminated infection with nonconventional regimens.","volume":"69","author":"Meyers","year":"2000","journal-title":"Transplantation"},{"key":"R37-7-20210129","first-page":"364","article-title":"Isoniazid hepatotoxicity after orthotopic liver transplantation.","volume":"63","author":"Schluger","year":"1996","journal-title":"Mt Sinai J Med"},{"key":"R38-7-20210129","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1399-0012.1992.tb00596.x","article-title":"Mycobacterium tuberculosis after liver transplantation: Management and guidelines for prevention.","volume":"6","author":"Higgins","year":"1992","journal-title":"Clin Transplant"},{"key":"R39-7-20210129","first-page":"905","article-title":"Successful treatment of multidrug-resistant tuberculosis following drug-induced hepatic necrosis requiring liver transplant.","volume":"8","author":"Marra","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"R40-7-20210129","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1111\/j.1600-6143.2005.01065.x","article-title":"Is liver transplantation advisable for isoniazid fulminant hepatitis in active extrapulmonary tuberculosis?","volume":"5","author":"Barcena","year":"2005","journal-title":"Am J Transplant"},{"key":"R41-7-20210129","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1097\/00007890-200209270-00029","article-title":"Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis.","volume":"74","author":"Singh","year":"2002","journal-title":"Transplantation"},{"key":"R42-7-20210129","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1572-0241.2002.05704.x","article-title":"Prevalence and interaction of hepatitis B and latent tuberculosis in Vietnamese immigrants to the United States.","volume":"97","author":"Patel","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R43-7-20210129","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1086\/323896","article-title":"Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis.","volume":"33","author":"Sadaphal","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R44-7-20210129","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1086\/345906","article-title":"Isoniazid hepatotoxicity among drug users: the role of hepatitis C.","volume":"36","author":"Fernandez-Villar","year":"2003","journal-title":"Clin Infect Dis"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007890-200706270-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T10:49:25Z","timestamp":1737110965000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-200706270-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,27]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000266578.45634.4f","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6,27]]}}}